Renalyte Medical
Fully Implantable Renal Assist
Company Overview
Snapshot
Founded in August 2021 by Nava Barit Ben-David, Renalyte Medical operates with 1–10 employees. The company is currently in the R&D product stage, developing a fully implantable renal-assist device.
Business overview
Renalyte Medical is innovating in kidney care by developing the first fully implantable renal-assist device designed to replace traditional dialysis. This technology aims to provide autonomous, 24/7 therapy, restoring patient freedom and reducing healthcare burdens. The company's platform is engineered for scalable evolution, starting with continuous hemofiltration and advancing towards fully implantable hemodiafiltration in future versions. Renalyte Medical operates within the Health Tech & Life Sciences sector, specifically focusing on medical devices and medical treatment & therapeutics, targeting healthcare providers and patients.
Company Intelligence Q&A
- What is Renalyte Medical's primary focus?
- Renalyte Medical is focused on redefining kidney care through the development of a fully implantable renal-assist device that provides autonomous, 24/7 therapy, aiming to replace traditional dialysis.
- When was Renalyte Medical founded?
- Renalyte Medical was founded in August 2021.
- Who is the co-founder and CEO of Renalyte Medical?
- Nava Barit Ben-David is the co-founder and CEO of Renalyte Medical.
- What is the current product stage of Renalyte Medical?
- Renalyte Medical is currently in the R&D product stage, developing its implantable renal-assist device.
- What is the long-term vision for Renalyte Medical's technology?
- Renalyte Medical's long-term vision involves scalable evolution of its platform, starting with continuous hemofiltration and advancing towards fully implantable hemodiafiltration in future versions to liberate patients from traditional dialysis.